Summit Behavioral Health has opened a new detoxification and residential treatment center, the sixth facility in its portfolio. Serenity at Summit New England, located in Haverhill, Mass., will offer a 23-bed detox and 20-bed residential program.
The organization, which is backed by private equity, purchased the Haverhill site and an existing hospital building that dates back to the 1870s. In the second phase for the new site, an additional 40 beds will open next spring in the refurbished four-story wing of the facility, which hasn’t been in use since the 1970s, according to CEO Jim Kane.
Kane says Massachusetts in particular is facing high demand for services because of the growing opioid addiction crisis. The state saw fewer than 400 opioid overdoses just a few years ago, but this year, the number could top 1,200, according to Kane.
Summit Behavioral Health currently has facilities in Massachusetts, New Jersey and Pennsylvania.
“We’ll look at new development in the New England and Mid-Atlantic area,” he tells Behavioral Healthcare. “And we’re pretty much looking at demand.”
Summit Behavioral Healthcare is increasingly including genetic testing in its clinical offerings to help determine optimal dosing for pain and psychotropic medications. Kane says insurance typically covers the cost, but out-of-pocket costs would be in the $500 range. He believes this type of individualized treatment will grow in the behavioral health field.